The cognitive sequelae of cancer and cancer-related treatment for non–central nervous system malignancies, referred to as cancer-related cognitive impairment (CRCI), occur in as many as 75% of patients with cancer during treatment and continue for years post-treatment in about 35% of these patients (Ahles & Root, 2018; Ahles & Saykin, 2007; Henneghan et al., 2021, 2023; Janelsins et al., 2014; Koppelmans et al., 2014; Wefel et al., 2004).
No takes yet. Share an insight, caveat, or question.
Myers et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: